Archaeologists were stunned after recently discovering one of the greatest works of Western literature placed on top of a mummy in Egypt. The one-of-a-kind discovery was announced by the University of ...

In the ancient Egyptian city of Oxyrhynchus, archaeologists recently discovered a 1,600-year-old tomb with several mummies inside. Some of them were decorated with gold leaf or geometric ...

The Oxyrhynchus Archaeological Mission, run by the Institute of Ancient Near East Studies (IPOA) at the University of Barcelona and led by Maite Mascort and Esther Pons, has identified a papyrus ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

A 2,000-year-old papyrus fragment, discovered in the archives of the French Institute of Oriental Archaeology in Cairo, reveals 30 previously unpublished verses by Empedocles, a pre-Socratic ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Researchers found a 3,300-year-old papyrus where an artist used white pigment to slim a jackal figure. The correction appears in a Book of the Dead created for the royal scribe Ramose. Analysis ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...